Treating progressive multifocal leukoencephalopathy with interleukin 7 and vaccination with JC virus capsid protein VP1

Clinical Infectious Diseases

Volumn 59, Issue 11, 2014, Pages 1588-1592

  Sospedra, Mireia ^a,b   Schippling, Sven ^a,b   Yousef, Sara ^a   Jelcic, Ilijas ^b   Bofill Mas, Silvia ^c   Planas, Raquel ^a,b   Stellmann, Jan Patrick ^a   Demina, Viktoria ^d   Cinque, Paola ^e   Garcea, Robert ^f   Croughs, Therese ^g   Girones, Rosina ^c   Martin, Roland ^a,b  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c UNIVERSITY OF BARCELONA   (Spain)

^d Life Science Inkubator   (Germany)

^e SAN RAFFAELE HOSPITAL   (Italy)

^f UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^g Cytheris SA   (France)

Author keywords

IL 7; JC virus; Progressive multifocal leukoencephalopathy; VP1

Indexed keywords

IMIQUIMOD; IMMUNOGLOBULIN G; RECOMBINANT INTERLEUKIN 7; RECOMBINANT JC VIRUS PROTEIN VP1; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; VIRUS ANTIBODY; CAPSID PROTEIN; INTERLEUKIN 7; RECOMBINANT VACCINE; VIRUS VACCINE;

ADJUVANT THERAPY; ANTIBODY RESPONSE; ARTICLE; CASE REPORT; CD4 CD8 RATIO; CD4+ T LYMPHOCYTE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; HUMAN; JC VIRUS; NUCLEAR MAGNETIC RESONANCE IMAGING; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; VACCINATION; VIRUS LOAD; BRAIN; CHEMISTRY; IMMUNOCOMPROMIZED PATIENT; IMMUNOLOGY; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; PATHOLOGY;

BRAIN; CAPSID PROTEINS; HUMANS; IMMUNOCOMPROMISED HOST; INTERLEUKIN-7; JC VIRUS; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; MAGNETIC RESONANCE IMAGING; VACCINES, SYNTHETIC; VIRAL VACCINES;

EID: 84924348262     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciu682     Document Type: Article

References (12)

1. Tan CS, Koralnik IJ. Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis. Lancet Neurol 2010; 9: 425-37.
2. Cinque P, Pierotti C, Vigano MG, et al. The good and evil of HAART in HIV-related progressive multifocal leukoencephalopathy. J Neurovirol 2001; 7: 358-63.
3. Aly L, Yousef S, Schippling S, et al. Central role of JC virus-specific CD4+ lymphocytes in progressive multi-focal leucoencephalopathyimmune reconstitution inflammatory syndrome. Brain 2011; 134(pt 9): 2687-702.
4. Gheuens S, Bord E, Kesari S, et al. Role of CD4+ and CD8+ T-cell responses against JC virus in the outcome of patients with progressive multifocal leukoencephalopathy (PML) and PML with immune reconstitution inflammatory syndrome. J Virol 2011; 85: 7256-63.
5. Gorelik L, Lerner M, Bixler S, et al. Anti-JC virus antibodies: implications for PML risk stratification. Ann Neurol 2010; 68: 295-303.
6. Mackall CL, Fry TJ, Gress RE. Harnessing the biology of IL-7 for therapeutic application. Nat Rev Immunol 2011; 5: 330-42.
7. Pellegrini M, Calzascia T, Toe JG, et al. IL-7 engages multiple mechanisms to overcome chronic viral infection and limit organ pathology. Cell 2011; 144: 601-13.
8. Feyeraband S, Stevanovic S, Gouttefangeas C, et al. Novel multi-peptide vaccination in HLA-A2+ hormone sensitive patients with biochemical relapse of prostate cancer. Prostate 2009; 69: 917-27.
9. Pal A, Sirota L, Maudru T, Peden K, Lewis AM. Real-time quantitative PCR assays for the detection of virus-specific DNA in samples with mixed populations of polyomaviruses. J Virol Methods 2006; 135: 32-42.
10. Goldmann C, Petry H, Frye S, et al. Molecular cloning and expression of major structural protein VP1 of the human polyomavirus JC virus: formation of virus-like particles useful for immunological and therapeutic studies. J Virol 1999; 73: 4465-9.
11. Weber T, Trebst C, Frye S, et al. Analysis of the systemic and intrathecal humoral immune response in progressive multifocal leukoencephalopathy. J Infect Dis 1997; 176: 250-4.
12. Reiber H, Lange P. Quantification of virus-specific antibodies in cerebrospinal fluid and serum: sensitive and specific detection of antibody synthesis in brain. Clin Chem 1991; 37: 1153-60.